About The Bulletin
October 2023 – Vol. 42, No. 9
Paths to Otolaryngology Leadership: Part I
Being an Academy member is not just about membership in your specialty society, it is a commitment to optimizing care and continually striving to improve patient outcomes.
Policy Ahead of Politics for a Healthier Healthcare Future
The Academy serves subspeciality areas by providing forums for leaders to work together on common problems, and to advocate on the regulatory and legislative spaces effectively.
Douglas D. Backous, MD, AAO-HNS/F President
Members as Change Agents for the Specialty and the AAO-HNS/F
Member engagement maximizes your membership and builds the Academy.
James C. Denneny III, MD, AAO-HNS/F Executive Vice President and CEO
Hearing Loss and Cognitive Decline: Results of the ACHIEVE Study
ACHIEVE study findings suggest that treating hearing loss may be a particularly important global public health target for dementia prevention efforts.
Attack of the Killer….Brisket?
Mammalian Meat Allergy or alpha-gal is an unusual variant of a Type 1 Immunoglobulin E [IgE]-mediated hypersensitivity reaction.
How Migraine Modulates Tinnitus
It has been found that migraine is more common in patients with tinnitus and subjective hearing loss.
Expanding Real-World Outcomes in Adults with Hearing Loss
To better understand the real-world effects of hearing loss on patients’ lives, it is imperative that we expand our outcome assessments in this patient population.
Simulation in Otology: New Options for Education and Training
Although traditional cadaveric temporal bone training remains the mainstay of otologic education, the value of simulation to address challenges and elevate and improve the education opportunities for learning is clear.
WIO Endowment Grants Garner Support with Increased Fundraising in 2023
The endowment provides grants to projects demonstrating a significant contribution to explore and advance the success of women in otolaryngology.
Pearls from Your Peers: Immunotherapy and the Changing Therapeutic Landscape for Cutaneous Squamous Cell Carcinoma
Exploring immunotherapy for patients with metastatic cutaneous squamous cell carcinoma.
Call for 2024 AAO-HNS Election Nominees
Recommend someone for elected office.
New Lifetime and 30-Year Members
Congratulations to these individuals who celebrate longevity in membership.
One Drop Less, University of Cape Coast School of Medicine, Ghana
AAO-HNSF Humanitarian Travel Grant Report.
2024-2025 Committee Cycle: Applications Open November 1
Prepare now to apply for the 2024-2025 AAO-HNS/F Committee Cycle.
Seeks “What’s on My Mind” Contributors
Do you have a hot-button topic you want to address?